PAIP2B

Across TCGA pan-cancer cohorts, PAIP2B Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated PAIP2B data layer compared with 21 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher PAIP2B Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated PAIP2B expression acts as an unfavorable survival marker.

SKCM, UCEC, and HNSC are the cancer types where PAIP2B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	All	0.244	0.739	<.001	27	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
HNSC	OS	Median	All	0.151	0.685	.007	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

PAIP2B–SKCM (DFS)

Open the SKCM breakdown →